Incorporation of fialuridine (FIAU) into mitochondrial DNA and effects of FIAU on the morphology of mitochondria in human hepatoblastoma cells

Toxicology in Vitro

Volumn 10, Issue 3, 1996, Pages 297-299

  Colacino, J M ^a,b   Horn, J W ^a,b   Horn, D M ^a,b   Richardson, F C ^a,b  

^a ELI LILLY AND COMPANY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS DNA; DIMETHYL SULFOXIDE; FIALURIDINE; MITOCHONDRIAL DNA; NUCLEOSIDE ANALOG; ZALCITABINE;

ANTIVIRAL ACTIVITY; ARTICLE; CELL ULTRASTRUCTURE; CONTROLLED STUDY; DRUG DISTRIBUTION; ELECTRON MICROSCOPY; HEP 2 CELL; HEPATITIS B VIRUS; HEPATOBLASTOMA; HUMAN; HUMAN CELL; LIVER MITOCHONDRION; MITOCHONDRION SWELLING; RADIOIMMUNOASSAY;

HEPATITIS B VIRUS;

EID: 0029954258     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/0887-2333(96)00016-1     Document Type: Article

References (24)

1. Berger A. R., Arezzo J. C., Schaumburg H. H., Skowron G., Merigan T., Bozzette S., Richman D. and Soo W. (1993) 2′,3′-Dideoxycytidine (ddC) toxic neuropathy: a study of 52 patients. Neurology 43, 358-362.
2. Bowsher R. R., Compton J. A., Kirkwood J. A., Place G. D., Jones C. D., Mabry T. E., Hyslop D. L., Hatcher B. L. and DeSante K. A. (1994) Sensitive and specific radioimmunoassay for fialuridine: initial assessment of pharmacokinetics after single oral doses to healthy volunteers. Antimicrobial Agents and Chemotherapy 38, 2134-2142.
3. Brivet F. G., Naveau S. H., Lemaigre G. F. and Dormont J. (1994) Pancreatic lesions in HIV-infected patients. Bailliere's Clinical Endocrinology and Metabolism 8, 859-877.
4. Chen C.-H. and Cheng Y.-C. (1989) Delayed cytotoxicity and selective loss of mitochondrial DNA in cells treated with the anti-human immunodeficiency virus compound 2′,3′-dideoxycytidine. Journal of Biological Chemistry 264, 11934-11937.
5. Chen M. S., Van Nostrand M. and Oshana S. C. (1986) Quantitative determination of antiviral nucleoside analog in DNA. Analytical Biochemistry 156, 300-304.
6. Cherrington J. M., Allen S. J., McKee B. H. and Chen M. S. (1994) Kinetic analysis of the interaction between the diphosphate of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, ddCTP, AZTTP, and FIAUTP with human DNA polymerases beta and gamma. Biochemical Pharmacology 48, 1986-1988.
7. Colacino J. M., Malcolm S. K. and Jaskunas S. R. (1994) Effect of fialuridine on replication of mitochondrial DNA in CEM cells and in human hepatoblastoma cells in culture. Antimicrobial Agents and Chemotherapy 38, 1997-2002.
8. Cui L., Yoon S., Schinazi R. F. and Sommadossi J.-P. (1995) Cellular and molecular events leading to mitochondrial toxicity of 1-(2-deoxy-2-fluoro-1-β-D-arabinofuranosyl)-5-iodouracil in human liver cells. Journal of Clinical Investigation 95, 555-563.
9. Flint O. P. (1994) In vitro studies of the toxicity of nucleoside analogues used in the treatment of HIV infection. Toxicology in Vitro 8, 677-683.
10. Fried M. W., DiBisceglie A. M., Straus S. E., Savarese B., Beames M. P. and Hoofnagle J. H. (1992) FIAU, a new oral anti-viral agent, profoundly inhibits HBV DNA in patients with chronic hepatitis B. Hepatology 16, 127a.
11. Grant A. J., Feinberg A., Chou T.-C., Watanabe K. A., Fox J. J. and Philips F. S. (1982) Incorporation of the metabolites of 2′-fluoro-5-iodo-1-β-D-arabinofuranosyl-cytosine into deoxyribonucleic acid of neoplastic and normal mammalian tissues. Biochemical Pharmacology 31, 1103-1108.
12. Klecker R. W., Katki A. G. and Collins J. M. (1994) Toxicity, metabolism, DNA incorporation with lack of repair, and lactate production for 1-(2′-fluoro-2′-deoxy-β-D-arabinofuranosyl)-5-iodouracil in U-937 and MOLT-4 cells. Molecular Pharmacology 46, 1204-1209.
13. Korba B. E. and Gerin J. L. (1992) Use of a standardized cell culture assay to assess activities of nucleoside analogs against hepatitis B virus replication. Antiviral Research 19, 55-70.
14. Lewis W. and Dalakas M. C. (1995) Mitochondrial toxicity of antiviral drugs. Nature Medicine 1, 417-422.
15. Lewis W., Gonzalez B., Chomyn A. and Papoian T. (1992) Zidovudine induces molecular, biochemical, and ultrastructural changes in rat skeletal muscle mitochondria. Journal of Clinical Investigation 89, 1354-1360.
16. Lewis W., Papoian T., Gonzalez B., Louie H., Kelly D. P., Payne R. M. and Grody W. W. (1991) Mitochondrial, ultrastructural and molecular changes induced by zidovudine in rat hearts. Laboratory Investigation 65, 228-236.
17. McKenzie R., Fried M. W., Sallie R., Conjeevaram H., DiBisceglie A. M., Park Y., Savarese B., Kleiner D., Tsokos M., Luciano T., Pruett T., Stotka J. L., Straus S. E. and Hoofnagle J. H. (1995) Hepatic failure and lactic acidosis due to flaluridine (FIAU), an investigational nucleotide analogue for chronic hepatitis B. New England Journal of Medicine 333, 1099-1105.
18. Medina D. J., Tsai C-H., Hsiung G. D. and Cheng Y.-C. (1994) Comparison of mitochondrial morphology, mitochondrial DNA content, and cell viability in cultured cells treated with three anti-human immunodeficiency virus dideoxynucleosides. Antimicrobial Agents and Chemotherapy 38, 1824-1828.
19. Parker W. B. and Cheng Y.-C. (1994) Mitochondrial toxicity of antiviral nucleoside analogs. Journal of NIH Research 5, 33-35.
20. Richardson F. C., Engelhardt J. A. and Bowsher R. R. (1994) Fialuridine accumulates in DNA of dogs, monkeys, and rats following long-term oral administration. Proceedings of the National Academy of Sciences of the U.S.A. 91, 12003-12007.
21. Staschke K. A., Colacino J. M., Mabry T. E. and Jones C. D. (1994) The in vitro anti-hepatitis B virus activity of FIAU [1-(2′-deoxy-2′-fluoro-1-β-D-arabinofuranosyl-5-iodo)uracil] is selective, reversible, and determined at least in part, by the host cell. Antiviral Research 23, 45-61.
22. Stevenson W., Gaffey M., Ishitani M., McCullough C., Dickson R., Caldwell S., Lobo P. and Pruett T. (1995) Clinical course of four patients receiving the experimental antiviral agent flaluridine for the treatment of chronic hepatitis B infection. Transplantation Proceedings 27, 1219-1221.
23. Swartz M. N. (1995) Mitochondrial toxicity - new adverse drug effects. New England Journal of Medicine 333, 1146-1148.
24. Tamura K. and Aotsuka T. (1988) Rapid isolation method of animal mitochondrial DNA by the alkaline lysis procedure. Biochemical Genetics 26, 815-819.